Pediatrix Medical Group (NYSE: MD) has announced that it will be unveiling its third quarter financial results on Friday 1st November 2024. This eagerly anticipated announcement is scheduled to occur before market open, ensuring that investors and analysts have the opportunity to gain valuable insights into the company's performance during the quarter.
According to financial analysts on Wall Street, the business is likely to announce an estimated per share $0.37 profit for the quarter. Additionally, the company is anticipated to reveal a total revenue of $498.87 million during this period.
Wall Street analysts have revealed their projections for the company's yearly performance, with a total revenue of $1.98 billion. Furthermore, they expect the business to achieve profit of $1.28 per share during the fiscal year.
In the previous year's corresponding quarter, the company's earnings report revealed a per-share income of $0.32. Moreover, the company achieved a remarkable total revenue of $506.61 million during that quarter.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.34 | -12.8% | 504.30 M | +0.7% |
| Q1 2024 | $0.20 | -13.0% | 495.10 M | +0.8% |
| Q4 2023 | $0.32 | -31.9% | 496.44 M | -3.4% |
| Q3 2023 | $0.32 | -20.0% | 506.61 M | +3.4% |
| Q2 2023 | $0.39 | -17.0% | 500.58 M | +3.0% |
| *Growth on year-over-year basis | ||||
The organization will host a conference call with investment community on 1st November 2024 at 09:00 AM eastern time to discuss the financial results.
During Wednesday's trading, Pediatrix Medical Group (MD) shares reached a low of $12.63 and a high of $13.01, along with a total volume of 602.60 thousand shares. The stock ended the regular trading session at $12.66, reflecting decline of 2.39 percent.
